samedan logo
 
 
spacer
home > white papers > pAVEway™ expression system for the efficient expression of therapeutic proteins - Fujifilm Diosynth Biotechnologies
WHITE PAPERS
logo_Fujifilm_D.JPG

Fujifilm Diosynth Biotechnologies

phone +44 (0)1642 363511
email enquiries@fujifilmdb.com
web http://www.fujifilmdiosynth.com
email Belasis Avenue, Billingham, TS23 1LH, UK

pAVEway™ expression system for the efficient expression of therapeutic proteins

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
pAVEway™ expression system for the efficient expression of therapeutic proteins
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

WuXi STA Forms Strategic Partnership with Coherent Biopharma

Shanghai, 1st December 2021: WuXi STA – a subsidiary of WuXi AppTec – and Coherent Biopharma, announced the signing of a strategic partnership agreement.
More info >>


White Papers


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement